MYDRIACYL

This brand name is authorized in United States. It is also authorized in Brazil, Canada, Ecuador, Estonia, Hong Kong SAR China, Lithuania, New Zealand, Singapore, UK.

Active ingredients

The drug MYDRIACYL contains one active pharmaceutical ingredient (API):

1	Tropicamide UNII N0A3Z5XTC6 - TROPICAMIDE
	Tropicamide is an anticholinergic which blocks the responses of the sphincter muscle of the iris and the ciliary muscle to cholinergic stimulation thus dilating the pupil (mydriasis).
	Read more about Tropicamide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MYDRIACYL Eye drops, solution	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01FA06	Tropicamide	S Sensory organs → S01 Ophthalmologicals → S01F Mydriatics and cycloplegics → S01FA Anticholinergics
Discover more medicines within S01FA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	500902901178316
CA	Health Products and Food Branch	00000981, 00001007
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	25.641-04-04
EE	Ravimiamet	1123850
GB	Medicines & Healthcare Products Regulatory Agency	39070
HK	Department of Health Drug Office	16911
LT	Valstybinė vaistų kontrolės tarnyba	1010021
NZ	Medicines and Medical Devices Safety Authority	942, 943
SG	Health Sciences Authority	04715P, 04721P
US	FDA, National Drug Code	0065-0355, 0998-0355